45 results
8-K
EX-10.2
KPRX
Kiora Pharmaceuticals Inc
1 Feb 21
Departure of Directors or Certain Officers
6:55am
Director Service Agreement as in effect immediately prior to February 1, 2021.
Item 4. "Bonus" shall be amended and read as follows:
4.1
The Managing … Director may – for his performance as Managing Director of the Company and as Acting CEO of EyeGate – be awarded a "Discretionary bonus" of up to 30
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
3 Dec 19
Departure of Directors or Certain Officers
6:55am
) weeks of Annual Base Salary.
b. Pro-Rated Bonus. The Company will make a lump-sum cash payment to the Participant in an amount equal to the sum … of:
(i) the Participant’s Target Annual Bonus Opportunity, multiplied by a fraction, (x) the numerator of which is the number of days elapsed
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
or as lawfully requested by the Employee.
8.2 Performance Bonus. The Employee shall be eligible to receive a performance bonus in respect of each … fiscal year of the Employer. Payment of any such performance bonus and the amount, if any, of any such performance bonus shall be entirely
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
or amounts to be withheld as shall be required under applicable law or as lawfully requested by the Employee.
8.2 Performance Bonus. The Employee shall … be eligible to receive a performance bonus in respect of each fiscal year of the Employer. Payment of any such performance bonus and the amount, if any
8-K
EX-10.1
nau8y6ssqnz yycid
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
wrj44hxu83f
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
nxqyew2gbdtm8v it6ij
1 Feb 21
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
cw4hjm5kz6
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
8-K
urrqh
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
y95g9shy
24 Mar 20
Departure of Directors or Certain Officers
4:15pm
8-K
w3vda491e11an8 t8r1b
26 Jul 21
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
4:18pm
8-K
7a7w v2ldyt
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-10.2
pul8u4d4by2d 8li
3 Dec 19
Departure of Directors or Certain Officers
6:55am
8-K
EX-10.1
qa5296yb1ohxiy1v
26 Apr 22
Departure of Directors or Certain Officers
6:51am